These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
58 related items for PubMed ID: 3873008
1. Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion. Van Cauter E, Refetoff S. N Engl J Med; 1985 May 23; 312(21):1343-9. PubMed ID: 3873008 [Abstract] [Full Text] [Related]
2. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL. N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991 [Abstract] [Full Text] [Related]
3. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W. N Engl J Med; 1986 May 22; 314(21):1329-35. PubMed ID: 3010108 [Abstract] [Full Text] [Related]
4. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies. Boscaro M, Sonino N, Rampazzo A, Menegus AM, Mantero F. Horm Metab Res Suppl; 1987 May 22; 16():60-2. PubMed ID: 2832292 [Abstract] [Full Text] [Related]
5. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome. Zacharieva S, Matrosov P, Stoeva I, Kirilov G. Exp Clin Endocrinol; 1989 Apr 22; 93(1):19-28. PubMed ID: 2544435 [Abstract] [Full Text] [Related]
6. Rhythms of pituitary-adrenal activity during sleep in patients with Cushing's disease. Bierwolf C, Kern W, Mölle M, Born J, Fehm HL. Exp Clin Endocrinol Diabetes; 2000 Apr 22; 108(7):470-9. PubMed ID: 11083068 [Abstract] [Full Text] [Related]
7. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J. N Engl J Med; 1992 Oct 01; 327(14):981-6. PubMed ID: 1325609 [Abstract] [Full Text] [Related]
8. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB, Loriaux DL. N Engl J Med; 1991 Sep 26; 325(13):897-905. PubMed ID: 1652686 [Abstract] [Full Text] [Related]
9. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma. Letizia C, Di Iorio R, De Toma G, Marinoni E, Cerci S, Celi M, Subioli S, D'Erasmo E. Metabolism; 2000 Jun 26; 49(6):760-3. PubMed ID: 10877203 [Abstract] [Full Text] [Related]
10. CRH in Cushing's syndrome. Müller OA, Stalla GK, von Werder K. Horm Metab Res Suppl; 1987 Jun 26; 16():51-8. PubMed ID: 2832289 [Abstract] [Full Text] [Related]
11. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease. van Aken MO, Pereira AM, van den Berg G, Romijn JA, Veldhuis JD, Roelfsema F. Clin Endocrinol (Oxf); 2004 Jun 26; 60(6):765-72. PubMed ID: 15163342 [Abstract] [Full Text] [Related]
12. Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment. van Waveren Hogervorst CO, Koppeschaar HP, Zelissen PM, Lips CJ, Garcia BM. J Clin Endocrinol Metab; 1996 Feb 26; 81(2):652-5. PubMed ID: 8636284 [Abstract] [Full Text] [Related]
14. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index. van Aken MO, Pereira AM, Frölich M, Romijn JA, Pijl H, Veldhuis JD, Roelfsema F. Am J Physiol Endocrinol Metab; 2005 Jan 26; 288(1):E63-70. PubMed ID: 15328071 [Abstract] [Full Text] [Related]
15. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG. Ann Acad Med Stetin; 2002 Jan 26; 48():283-300. PubMed ID: 14601484 [Abstract] [Full Text] [Related]
16. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A, Murray RD, Teasdale GM, Shalet SM. Clin Endocrinol (Oxf); 2004 Apr 26; 60(4):476-83. PubMed ID: 15049963 [Abstract] [Full Text] [Related]
17. Results of treating childhood Cushing's disease with pituitary irradiation. Jennings AS, Liddle GW, Orth DN. N Engl J Med; 1977 Nov 03; 297(18):957-62. PubMed ID: 909542 [Abstract] [Full Text] [Related]
18. [Clinical study on Cushing's syndrome]. Miyachi Y. Nihon Naika Gakkai Zasshi; 1992 Sep 10; 81(9):1533-8. PubMed ID: 1333510 [No Abstract] [Full Text] [Related]
19. Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease. Krieger DT, Howanitz PJ, Frantz AG. J Clin Endocrinol Metab; 1976 Feb 10; 42(2):260-72. PubMed ID: 816805 [Abstract] [Full Text] [Related]
20. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW. Neuroendocrinology; 1993 Jan 10; 57(1):79-88. PubMed ID: 8097579 [Abstract] [Full Text] [Related] Page: [Next] [New Search]